Cheyne Capital Management (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$11.7M Buy
20,154
+1,184
+6% +$691K 42.18% 1
2023
Q3
$10.2M Buy
18,970
+4,010
+27% +$2.07M 29.36% 1
2023
Q2
$7.02M Sell
14,960
-3,540
-19% -$1.48M 25.85% 1
2023
Q1
$6.35M Buy
+18,500
New +$6.24M 20.14% 1

Other funds holding LLY

Cheyne Capital Management (UK)'s LLY Position: Q4 2023 in Review

Cheyne Capital Management (UK) increased its Eli Lilly (LLY) stake by 6.2% in Q4 2023, buying an estimated $691K and bringing the position to 20,154 shares worth $11.7M. The position accounts for 42.18% of the portfolio, ranked #1.

Cheyne Capital Management (UK) first reported a position in LLY in Q1 2023 and has held it in 4 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Cheyne Capital Management (UK) held 20,154 shares of Eli Lilly worth $11.7M as of Q4 2023.
  • Cheyne Capital Management (UK) bought 1,184 Eli Lilly shares in Q4 2023, an estimated $691K.
  • Eli Lilly made up 42.18% of Cheyne Capital Management (UK)'s portfolio in Q4 2023, its #1 holding.
  • Cheyne Capital Management (UK) first reported a position in Eli Lilly in Q1 2023 and has held it in 4 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2023, filed 12 Feb 2024.